De Cristofaro, Raimondo
 Distribuzione geografica
Continente #
EU - Europa 3235
NA - Nord America 2742
AS - Asia 673
AF - Africa 24
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 6697
Nazione #
US - Stati Uniti d'America 2725
DE - Germania 1286
SE - Svezia 709
CN - Cina 503
UA - Ucraina 454
IT - Italia 215
FR - Francia 173
PL - Polonia 119
GB - Regno Unito 105
FI - Finlandia 93
IN - India 59
TR - Turchia 37
IR - Iran 19
JP - Giappone 19
NL - Olanda 16
BE - Belgio 15
CA - Canada 14
RU - Federazione Russa 11
CI - Costa d'Avorio 10
RO - Romania 9
IE - Irlanda 8
VN - Vietnam 8
MK - Macedonia 6
EG - Egitto 5
ID - Indonesia 5
AU - Australia 4
BR - Brasile 4
EU - Europa 4
ZA - Sudafrica 4
A2 - ???statistics.table.value.countryCode.A2??? 3
HK - Hong Kong 3
IQ - Iraq 3
TN - Tunisia 3
AR - Argentina 2
AT - Austria 2
BD - Bangladesh 2
CZ - Repubblica Ceca 2
ES - Italia 2
GR - Grecia 2
IL - Israele 2
KW - Kuwait 2
LV - Lettonia 2
NO - Norvegia 2
PR - Porto Rico 2
SG - Singapore 2
A1 - ???statistics.table.value.countryCode.A1??? 1
AM - Armenia 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
HU - Ungheria 1
KR - Corea 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
MX - Messico 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
VE - Venezuela 1
Totale 6697
Città #
Chandler 601
Jacksonville 248
San Mateo 212
Nanjing 157
Ashburn 142
Wilmington 136
Ann Arbor 112
Warsaw 104
Woodbridge 98
Dearborn 88
Boston 86
Fairfield 77
Houston 71
Lawrence 71
Redwood City 71
Nürnberg 65
Princeton 54
Seattle 54
Cattolica 53
Nanchang 52
Beijing 49
Marseille 44
Redmond 44
Milan 37
Izmir 34
University Park 33
Bremen 32
Chicago 29
Hangzhou 29
Kunming 27
Mountain View 25
Augusta 23
Norwalk 22
Changsha 21
Shenyang 21
Detroit 18
Bareggio 17
Hebei 17
Cambridge 15
Jiaxing 15
Tianjin 15
Zhengzhou 15
Brussels 14
Kraków 14
Munich 14
Boardman 13
Leawood 12
Shanghai 12
Padova 11
Abidjan 10
Andover 10
Hefei 10
Lanzhou 10
Southend 10
Fremont 9
Jinan 9
Chengdu 8
San Diego 8
Lancaster 7
Rome 7
Ardabil 6
Phoenix 6
Prilep 6
Kish 5
Menlo Park 5
Ningbo 5
Simi Valley 5
Dong Ket 4
Falls Church 4
Guangzhou 4
Gurgaon 4
Hanoi 4
Indiana 4
London 4
Los Angeles 4
Millbury 4
Philadelphia 4
San Francisco 4
Timisoara 4
Tokyo 4
Castelnuovo Rangone 3
Changchun 3
Colombes 3
Costa Mesa 3
Duncan 3
Garden City 3
Mannheim 3
Mumbai 3
Ottawa 3
Sacramento 3
Taizhou 3
Toronto 3
Amsterdam 2
Baotou 2
Berlin 2
Buenos Aires 2
Changzhou 2
Chatsworth 2
Chieti 2
Clearwater 2
Totale 3464
Nome #
Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment 260
Qualitative and quantitative modifications of von willebrand factor in patients with essential thrombocythemia and controlled platelet count 252
The oxidative modification of von Willebrand factor is associated with thrombotic angiopathies in diabetes mellitus. 237
Pathogenesis Of Portal Vein Thrombosis In Liver Cirrhosis: The Role of the ADAMTS13/VWF Unbalance 212
Novel path to IL-6 trans-signaling through thrombin-induced soluble IL-6 receptor release by platelets 115
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 110
The Type 2b P.R1306w Natural Mutation Of Von Willebrand Factor Dramatically Enhances The Multimer Sensitivity To Shear Stress 107
Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors 105
Glycaemic variability affects ischaemia-induced angiogenesis in diabetic mice. 98
Effect of fibrinogen concentration on the velocity of platelet aggregation. 97
An old drug for a new application: carbazochrome-sodium-sulfonate in HHT 89
Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13. A new prothrombotic mechanism associated with oxidative stress 88
Cyclooxygenase-2 (COX-2) inhibition constrains indoleamine 2,3-dioxygenase 1 (IDO1) activity in acute myeloid leukaemia cells 82
Oxidized von Willebrand factor is efficiently cleaved by serine proteases from primary granules of leukocytes: divergence from adamts-13 81
Evaluation of the thiobarbituric acid test (TBA test) properties for the determination of glycosylated hemoglobins by comparison with chromatography and isoelectrofocusing. 78
β2-Glycoprotein I Binds Thrombin and Selectively Inhibits the Enzyme Procoagulant Functions 77
Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle 76
Pseudo-acquired vWD in essential thrombocythemia: the role of platelets 76
Structural and funtional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib 72
The D173G mutation in ADAMTS-13 causes a severe form of congenital thrombotic thrombocytopenic purpura. A clinical, biochemical and in silico study 71
Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders. 70
Kinetic study of von Willebrand factor self-aggregation induced by ristocetin 68
Evaluation of assay methods to measure plasma ADAMTS13 activity in thrombotic microangiopathies. 66
PURIFICATION OF THE ISOLATED BETA-CHAIN OF ADULT HUMAN-HEMOGLOBIN FROM ITS POST-TRANSLATIONAL MODIFICATION 65
Homocysteinemia is inversely correlated with platelet count and inversely correlated with sE-and sP-selectin levels in females homozygous for C677T methylenetetrahydrofolate reductase 64
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives 64
Hexopeptidase high performance liquid chromatography (HPLC) mapping and is application to peptide sequence strategies. 63
Congenital prothrombin deficiency: an update 63
Placental-derived PGI2 inhibits cord blood platelet function 62
Immune toilerance by intermittent factor VIII boluses in two hemophilia A patients 62
Allosteric equilibria in the binding reaction of fibrinogen to platelets. 62
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 60
Placental derived PGI2 inhibits cord platelet function:possible role of PGI in THR transient hyporeactivity of newborn platelets 59
high performance liquid chromatography in protein sequence determination. 58
SPONTANEOUS DEEP HEMATOMAS IN 2 PATIENTS WITH MYELOFIBROSIS - EVIDENCE OF PLATELET MEMBRANE GLYCOPROTEIN MODIFICATIONS 57
Biochemical properties of indoleamine 2,3-dioxygenase: from structure to optimized design of inhibitors 57
β2 -Glycoprotein I binds to thrombin and selectively inhibits the enzyme procoagulant functions 57
Portal vein thrombosis occurrence in a cirrhotic patient during treatment with rivaroxaban 57
Aims: The ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation (ORIGAMI) study investigates the safety and efficacy of Edoxaban administered via PEG in patients with atrial fibrillation and a clinical indication for a long-term anticoagulation. Design: In this prospective, single-centre observational study, 12 PEG-treated patients with indication to anticoagulation will receive edoxaban via PEG and will be followed up to 6 months. Plasma antifactor Xa activity and edoxaban concentrations will be assessed. Thromboembolic (ischaemic stroke, systemic embolism, venous thromboembolism) and bleeding events (Bleeding Academic Research Consortium and Thrombolysis in Myocardial Infarction) will be recorded at 1 and 6 months. Preliminary results: A retrospective analysis of five atrial fibrillation cases undergoing PEG implantation at our Institution who received edoxaban via PEG showed plasma anti-FXa levels at a steady state of 146 ± 15 ng/ml, without major adverse event at a mean follow-up of 6 months. Conclusion: ORIGAMI prospectively investigates PEG-administration of edoxaban in PEG-treated patients requiring long-term anticoagulation. Our preliminary retrospective data support this route of DOAC administration. 57
Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study 56
The expanding spectrum of PRPS1-associated phenotypes: three novel mutations segregating with X-linked hearing loss and mild peripheral neuropathy 55
Haemostatic system in inflammatory bowel diseases: new players in gut inflammation. 54
Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector. 54
A recurrent Gly43Asp substitution in coagulation Factor X rigidifies its catalytic pocket and impairs catalytic activity and intracellular trafficking 53
Ristocetin-induced self-aggregation of von Willebrand factor. 52
Another family with IGPS 52
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study 52
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study 52
Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects 51
The effect of shear stress on protein conformation: Physical forces operating on biochemical systems: The case of von Willebrand factor. 51
Proteolytic Processing of Von Willebrand Factor by Adamts13 and Leukocyte Proteases 51
Molecular Aggregation of Marketed Recombinant FVIII Products: Biochemical Evidence and Functional Effects 51
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response 50
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 50
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 49
INHIBITION OF FIBRINOGEN BINDING TO HUMAN-PLATELETS BY BLOCKAGE OF NA+/H+ EXCHANGE. 49
Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter 49
Wiskott-Aldrich syndrome: report of an autosomal dominant variant 49
The linkage between binding of the C-terminal domain of hirudin and amidase activity in human alpha-thrombin 48
Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma 48
Molecular Aggregation of Marketed Recombinant FVIII Products: Biochemical Evidence and Functional Effects. 48
Hemophilia A and von Willebrand deficiency: therapeutic implications 48
Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma 48
The dominant-negative von Willebrand factor gene deletion p.P1127_C1948delinsR: molecular mechanism and modulation. 47
Relevance of chloride binding to von Willebrand factor in type 2B von Willebrand disease patients 46
Thrombin interaction with platelet GpIB: role of the heparin binding domain. 45
Inherited macrothrombocytopenia with distinctive platelet ultrastructural and functional features 45
Mechanistic studies on ADAMTS13 catalysis. 45
Allosteric modulation of BPTI interaction with human alpha- and zeta-thrombin. 44
High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism 44
Carbon monoxyde and oxygen binding to human hemoglobin F0. 44
Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey 44
Direct oral anticoagulants and therapeutic adherence: do not let your guard down 43
Binding of human alpha-thrombin to platelet GpIb: energetics and functional effects. 42
Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D9D3 and D4 domains 42
Congenital prothrombin deficiency 41
Measurement of plasma fibrinogen concentration by the prothrombin-time-derived method: applicability and limitations. 41
Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients? 41
Detection of Platelet-Activating Antibodies Associated with Vaccine-Induced Thrombotic Thrombocytopenia by Flow Cytometry: An Italian Experience 41
Fibrinogen-elongated gamma chain inhibits thrombin-induced platelet response, hindering the interaction with different receptors 40
Diagnosis and management of cerebral venous sinus thrombosis in children: a single-center retrospective analysis 40
KINETIC ASPECTS OF RELEASE OF FIBRINOPEPTIDES AP AND AY BY HUMAN ALPHA-THROMBIN 39
Mechanistic studies on ADAMTS13 catalysis 39
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 38
Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus. 37
Fibrinogen-elongated gamma chain inhibits thrombin-induced platelet response, hindering the interaction with different receptors 37
Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter 37
Sustained safe and effective anticoagulation using Edoxaban via percutaneous endoscopic gastrostomy 37
From angiotensin-converting enzyme 2 disruption to thromboinflammatory microvascular disease: A paradigm drawn from COVID-19 37
Oral anticoagulants in fragile patients with percutaneous endoscopic gastrostomy and atrial fibrillation: the ORIGAMI pilot investigation 37
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 36
Mechanochemistry of von Willebrand factor 36
Italian intersociety consensus on DOAC use in internal medicine 35
Nucleotide-derived thrombin inhibitors: a new tool for an old issue 34
Apixaban Interacts with Haemoglobin: Effects on Its Plasma Levels 34
The P303T mutation in the human factor VII (FVII) gene alters the conformational state of the enzyme and causes a severe functional deficiency. 33
The use of viscoelastic haemostatic assays in non-cardiac surgical settings: A systematic review and meta-analysis 32
Thermodynamics of substrates and reversible inhibitors binding to the active site cleft of human alpha-thrombin. 32
Oxidation of Met1606 in von Willebrand factor is a risk factor for thrombotic and septic complications in chronic renal failure 31
TEMPERATURE-DEPENDENCE AND PH-DEPENDENCE OF THE OXYGEN-BINDING REACTION OF HUMAN-FETAL HEMOGLOBIN. 31
Totale 6221
Categoria #
all - tutte 13256
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13256


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018177 0000 00 067 5481434
2018/2019557 45524 8774 10628 43437761
2019/20201232 248549285 78124 12734 7971133107
2020/2021993 3611227100 15050 10818 1177616633
2021/20221119 831142462 6435 34172 6054203214
2022/20231470 263318164259 154231 810 0000
Totale 6782